Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA)
Snibe MAGLUMI C-Peptide (CLIA)
Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA) Snibe MAGLUMI C-Peptide (CLIA)

Snibe MAGLUMI C-Peptide (CLIA)

Product Details:

  • Accuracy <10% CV (as per kit insert)
  • Display Type Not Applicable (depends on instrument)
  • Shelf Life 12 months from production date
  • Instruments Type For use with MAGLUMI CLIA analyzers
  • Features High sensitivity, specific for C-Peptide, fully automated procedure, intended for clinical laboratory use
  • Function C-Peptide quantification for clinical diagnostics
  • Usage Type Laboratory
  • Click to View more
X

Snibe MAGLUMI C-Peptide (CLIA) Price And Quantity

Snibe MAGLUMI C-Peptide (CLIA) Product Specifications

  • Yes
  • Not Applicable (used in compatible analyzer)
  • No
  • New
  • Immunoassay Analyzer Reagents
  • Store at 2-8C, do not freeze
  • High sensitivity, specific for C-Peptide, fully automated procedure, intended for clinical laboratory use
  • 0.05 - 30 ng/mL (as per product documentation)
  • Kit box: standard packaging (White/Blue)
  • Laboratory
  • Automatic (for use with MAGLUMI systems)
  • <10% CV (as per kit insert)
  • Chemiluminescent Immunoassay (CLIA)
  • Kit packaging: as per standard (Refer to Snibe documentation)
  • No
  • For use with MAGLUMI CLIA analyzers
  • Quantitative determination of C-Peptide in human serum or plasma
  • Diagnostic reagent kit for in vitro use
  • Not Applicable (depends on instrument)
  • 12 months from production date
  • C-Peptide quantification for clinical diagnostics
  • Kit packaging: as per standard (Refer to Snibe documentation)
  • 0.02 ng/mL
  • Reagent kit includes calibrators, controls, magnetic microbeads, enzyme label, wash solution, and instructions for use
  • Two-step sandwich immunoassay with chemiluminescent detection
  • MAGLUMI series automated immunoassay analyzers
  • Within 30 minutes (as per analyzer protocol)
  • IVD (In Vitro Diagnostic) CE marked
  • 50 L
  • Minimal interference from common interfering substances (refer to kit insert for details)
  • Medical laboratories, hospitals, clinical diagnostic centers

Product Description

Brand Snibe
Sample Type Serum
Pack Size 100T
CAT No. 130255001M
Application Gastro-Intestinal

The kit has been designed for the quantitative determination of C-Peptide in human serum. The method can be used for samples over the range of 0.01-20.0ng/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).



High Sensitivity and Specificity

The Snibe MAGLUMI C-Peptide (CLIA) kit is engineered to achieve highly sensitive and specific detection of C-Peptide levels in clinical samples. With an impressive measurement range of 0.05 to 30 ng/mL and a limit of detection of 0.02 ng/mL, it ensures trustworthy results, helping healthcare providers make informed therapeutic decisions.


Fully Automated Workflow

This reagent kit is designed for automatic use on MAGLUMI series immunoassay analyzers, reducing hands-on time and enhancing laboratory productivity. The two-step sandwich immunoassay efficiently processes samples-requiring only 50 L-and delivers results within 30 minutes, making it suitable for high-throughput clinical environments.


Comprehensive and Reliable Kit Contents

Each MAGLUMI C-Peptide kit comes complete with all necessary components for accurate testing: calibrators, controls, magnetic microbeads, enzyme labels, and dedicated wash solutions. Detailed instructions ensure smooth setup, use, and maintenance, adhering to stringent IVD CE regulatory requirements.

FAQ's of Snibe MAGLUMI C-Peptide (CLIA):


Q: How does the Snibe MAGLUMI C-Peptide (CLIA) test work?

A: The kit operates via a two-step sandwich immunoassay principle combined with chemiluminescent detection. After sample introduction, target C-Peptide is captured and detected by labeled antibodies, resulting in a chemiluminescent signal that is directly proportional to the C-Peptide concentration in the sample.

Q: What is the sample volume required and how quickly are results available?

A: Only 50 L of serum or plasma is needed per sample. Results are generated within 30 minutes as per the analyzer protocol, supporting rapid clinical decision-making.

Q: Where can the MAGLUMI C-Peptide kit be used?

A: This kit is intended for use in medical laboratories, hospitals, and clinical diagnostic centers equipped with compatible MAGLUMI series automated immunoassay analyzers.

Q: What benefits does this reagent kit offer for clinical diagnostics?

A: The kit provides reliable, precise quantification of C-Peptide with high sensitivity, automated workflow, and minimal interference from common substances, allowing for efficient and accurate diabetes assessment and management.

Q: How should the MAGLUMI C-Peptide (CLIA) reagent kit be stored?

A: Store the kit at 2-8C and avoid freezing. Proper storage is crucial to maintain reagent stability and performance for up to 12 months from the production date.

Q: When should calibration and control checks be performed with this kit?

A: Calibration and control verification should follow the instructions in the kit insert and your laboratory's quality protocols-typically with each new reagent batch, after instrument maintenance, and as part of regular quality checks to ensure test accuracy.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical CLIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.